FibroGen: 4Q Earnings Snapshot

SAN FRANCISCO (AP) _ FibroGen Inc. (FGEN) on Monday reported a fourth-quarter loss of $98.1 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the San Francisco-based company said it had a loss of $1.12.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.

The biotech drug developer posted revenue of $8 million in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $30.7 million.

For the year, the company reported that its loss narrowed to $77 million, or 89 cents per share. Revenue was reported as $256.6 million.

FibroGen shares have climbed nearly 1% since the beginning of the year. In the final minutes of trading on Monday, shares hit $43.15, a decline of 28% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN